136 related articles for article (PubMed ID: 31611737)
1. Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer.
Farajihaye Qazvini F; Samadi N; Saffari M; Emami-Razavi AN; Shirkoohi R
EXCLI J; 2019; 18():530-539. PubMed ID: 31611737
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
[TBL] [Abstract][Full Text] [Related]
3. Implication of Bcl-2-associated athanogene 3 in fibroblast growth factor-2-mediated epithelial-mesenchymal transition in renal epithelial cells.
Du F; Li S; Wang T; Zhang HY; Li DT; Du ZX; Wang HQ
Exp Biol Med (Maywood); 2015 May; 240(5):566-75. PubMed ID: 25361773
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibroblast growth factor (FGF)-10 in human colorectal adenocarcinoma cells.
Matsuike A; Ishiwata T; Watanabe M; Asano G
J Nippon Med Sch; 2001 Oct; 68(5):397-404. PubMed ID: 11598623
[TBL] [Abstract][Full Text] [Related]
5. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
Strutz F; Zeisberg M; Ziyadeh FN; Yang CQ; Kalluri R; Müller GA; Neilson EG
Kidney Int; 2002 May; 61(5):1714-28. PubMed ID: 11967021
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
8. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
Jägle S; Dertmann A; Schrempp M; Hecht A
Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
[TBL] [Abstract][Full Text] [Related]
10. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
Su F; Wang BF; Zhang T; Hou XM; Feng MH
Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
[TBL] [Abstract][Full Text] [Related]
11. Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma.
Li Q; Li Y; Xu J; Wang S; Xu Y; Li X; Cai S
Cell Physiol Biochem; 2017; 42(1):397-406. PubMed ID: 28558381
[TBL] [Abstract][Full Text] [Related]
12. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
13. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.
Öner MG; Rokavec M; Kaller M; Bouznad N; Horst D; Kirchner T; Hermeking H
Gastroenterology; 2018 Dec; 155(6):1868-1882. PubMed ID: 30099074
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
15. The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma.
Niknami Z; Eslamifar A; Emamirazavi A; Ebrahimi A; Shirkoohi R
EXCLI J; 2017; 16():1009-1017. PubMed ID: 28900381
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.
Savagner P; Vallés AM; Jouanneau J; Yamada KM; Thiery JP
Mol Biol Cell; 1994 Aug; 5(8):851-62. PubMed ID: 7803853
[TBL] [Abstract][Full Text] [Related]
18. NEDD9 expression is correlated with epithelial-to-mesenchymal transition markers in colorectal cancer.
Xue YZ; Wu TL; Dai YY; Sheng YY; Wu YM; Xia BL; Huang ZW
Int J Clin Exp Pathol; 2017; 10(8):8640-8646. PubMed ID: 31966721
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
20. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
[Next] [New Search]